PIM
VERA icon

Platinum Investment Management’s Vera Therapeutics VERA Stock Holding History

Platinum Investment Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88M Hold
113,687
– – 1.2% 25
2026
Q1 		$4.57M Sell
113,687
-5,697
-5% -$245K 1.15% 27
2025
Q4 		$6.05M Sell
119,384
-40,367
-25% -$1.43M 1.4% 16
2025
Q3 		$4.64M Hold
159,751
– – 0.3% 37
2025
Q2 		$3.76M Buy
159,751
+20,433
+15% +$459K 0.25% 40
2025
Q1 		$3.35M Buy
139,318
+19,654
+16% +$632K 0.19% 39
2024
Q4 		$5.06M Sell
119,664
-17,725
-13% -$785K 0.3% 34
2024
Q3 		$6.07M Buy
137,389
+973
+0.7% +$36.9K 0.27% 35
2024
Q2 		$4.94M Sell
136,416
-17,516
-11% -$695K 0.2% 38
2024
Q1 		$6.64M Sell
153,932
-46,370
-23% -$1.65M 0.27% 35
2023
Q4 		$3.08M Hold
200,302
– – 0.13% 67
2023
Q3 		$2.75M Sell
200,302
-9,398
-4% -$161K 0.11% 67
2023
Q2 		$3.37M Buy
+209,700
New +$1.89M 0.12% 69

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Platinum Investment Management's VERA Position: Q2 2026 in Review

Platinum Investment Management held its Vera Therapeutics (VERA) position steady in Q2 2026 at 113,687 shares worth $4.88M. The position accounts for 1.2% of the portfolio, ranked #25.

Platinum Investment Management first reported a position in VERA in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.64M in Q1 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Platinum Investment Management held 113,687 shares of Vera Therapeutics worth $4.88M as of Q2 2026.
  • Platinum Investment Management left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up 1.2% of Platinum Investment Management's portfolio in Q2 2026, its #25 holding.
  • Platinum Investment Management first reported a position in Vera Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Platinum Investment Management's Vera Therapeutics position peaked at $6.64M in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.